Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol EC-FV-03: A Phase II Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung

NCT00511485 is registered in ClinicalTrials.gov with Endocyte as lead sponsor.

NCT NCT00511485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00511485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol EC-FV-03: A Phase II Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung
Lead sponsor
Endocyte
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
November 30, 2009
Enrollment
43 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the lung